Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors

NCT05676489 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT05676489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05676489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 1, 2027
Completion date
August 30, 2029
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases from extra-cranial solid tumors, healthy volunteers, recurrent glioma